# DYG Versus Cetrorelix in Oocyte Donation

> **NCT05577806** · — · COMPLETED · sponsor: **Clinica de la Mujer Medicina Reproductiva, Chile** · enrollment: 202 (estimated)

## Conditions studied

- Infertility, Female
- Fertility Disorders

## Interventions

- **DRUG:** Dydrogesterone

## Key facts

- **NCT ID:** NCT05577806
- **Lead sponsor:** Clinica de la Mujer Medicina Reproductiva, Chile
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 202 (ESTIMATED)
- **Last updated:** 2022-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05577806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05577806, "DYG Versus Cetrorelix in Oocyte Donation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05577806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*